Discontinued — last reported Q4 '25
Long-Term Debt
Non-Current LiabilitiesEli Lilly Long-Term Debt decreased by 0.0% to $40.87B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 43.3%, from $28.53B to $40.87B. Over 5 years (FY 2020 to FY 2025), Long-Term Debt shows an upward trend with a 19.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase signals higher financial leverage and future interest expense, whereas a decrease indicates debt repayment and a stronger balance sheet.
Detailed definition
Loans and financial obligations with a maturity date exceeding one year from the balance sheet date. This represents the...
Peer comparison
Large-cap tech companies often use long-term debt to take advantage of low interest rates even when they have significant cash holdings.
long_term_debtHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.74B | $15.52B | $15.35B | $15.15B | $14.69B | $14.14B | $14.74B | $18.88B | $18.16B | $17.92B | $18.32B | $24.56B | $23.73B | $29.05B | $28.53B | $34.50B | $34.18B | $40.87B | $40.87B |
| QoQ Change | — | +5.3% | -1.1% | -1.3% | -3.0% | -3.7% | +4.2% | +28.1% | -3.8% | -1.3% | +2.2% | +34.1% | -3.4% | +22.4% | -1.8% | +20.9% | -0.9% | +19.6% | -0.0% |
| YoY Change | — | — | — | — | -0.3% | -8.9% | -4.0% | +24.6% | +23.6% | +26.7% | +24.3% | +30.1% | +30.7% | +62.1% | +55.7% | +40.5% | +44.0% | +40.7% | +43.3% |
Long-Term Debt at Other Companies
Frequently Asked Questions
- What is Eli Lilly's long-term debt?
- Eli Lilly (LLY) reported long-term debt of $40.87B in Q4 2025.
- How has Eli Lilly's long-term debt changed year-over-year?
- Eli Lilly's long-term debt increased by 43.3% year-over-year, from $28.53B to $40.87B.
- What is the long-term trend for Eli Lilly's long-term debt?
- Over 5 years (2020 to 2025), Eli Lilly's long-term debt has grown at a 19.8% compound annual growth rate (CAGR), from $16.59B to $40.87B.
- What does long-term debt mean?
- Money borrowed by the company that is not due to be paid back for at least one year.